The North America Thyroid Function Testing Market would witness market growth of 5.7% CAGR during the forecast period (2023-2031).
The US market dominated the North America Thyroid Function Testing Market by Country in 2023 and would continue to be a dominant market till 2031; thereby, achieving a market value of $2,070.5 million by 2031. The Canada market is experiencing a CAGR of 8.1% during (2024 - 2031). Additionally, The Mexico market would exhibit a CAGR of 7.2% during (2024 - 2031).
The market is pivotal in diagnosing and managing thyroid disorders, affecting millions. It encompasses a range of diagnostic assays and methodologies to evaluate the thyroid glands hormone production and regulatory functions. From routine screening to monitoring treatment response, this is indispensable in clinical practice, catering to diverse patient populations across various healthcare settings.
Thyroid function testing has many applications in clinical practice, playing a crucial role in diagnosing, managing, and monitoring thyroid disorders. For example, thyroid function tests are commonly used for population-wide screening to detect thyroid dysfunction, including hypothyroidism, hyperthyroidism, and thyroid nodules. Screening helps identify individuals at risk of thyroid disorders, facilitating early diagnosis and intervention to prevent complications.
High rates of thyroid cancer in Canada may lead to increased awareness and screening for thyroid disorders, including routine testing. The Canadian Cancer Society reports that 6,300 Canadians were diagnosed with thyroid cancer, and 270 Canadians lost their lives to the disease in 2023. Among them, 1,900 men were diagnosed with thyroid cancer, and 120 died from it. In conclusion, the high rates of thyroid cancer and increasing awareness about thyroid disorders are driving the growth of the market.
Based on End-use, the market is segmented into Hospitals, Diagnostic Laboratories, Clinics, and Research Laboratories & Institutes. Based on Test Type, the market is segmented into TSH Test, Free T4 Test, T4 Test, T3 Test, Free T3 Test, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The US market dominated the North America Thyroid Function Testing Market by Country in 2023 and would continue to be a dominant market till 2031; thereby, achieving a market value of $2,070.5 million by 2031. The Canada market is experiencing a CAGR of 8.1% during (2024 - 2031). Additionally, The Mexico market would exhibit a CAGR of 7.2% during (2024 - 2031).
The market is pivotal in diagnosing and managing thyroid disorders, affecting millions. It encompasses a range of diagnostic assays and methodologies to evaluate the thyroid glands hormone production and regulatory functions. From routine screening to monitoring treatment response, this is indispensable in clinical practice, catering to diverse patient populations across various healthcare settings.
Thyroid function testing has many applications in clinical practice, playing a crucial role in diagnosing, managing, and monitoring thyroid disorders. For example, thyroid function tests are commonly used for population-wide screening to detect thyroid dysfunction, including hypothyroidism, hyperthyroidism, and thyroid nodules. Screening helps identify individuals at risk of thyroid disorders, facilitating early diagnosis and intervention to prevent complications.
High rates of thyroid cancer in Canada may lead to increased awareness and screening for thyroid disorders, including routine testing. The Canadian Cancer Society reports that 6,300 Canadians were diagnosed with thyroid cancer, and 270 Canadians lost their lives to the disease in 2023. Among them, 1,900 men were diagnosed with thyroid cancer, and 120 died from it. In conclusion, the high rates of thyroid cancer and increasing awareness about thyroid disorders are driving the growth of the market.
Based on End-use, the market is segmented into Hospitals, Diagnostic Laboratories, Clinics, and Research Laboratories & Institutes. Based on Test Type, the market is segmented into TSH Test, Free T4 Test, T4 Test, T3 Test, Free T3 Test, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
List of Key Companies Profiled
- Quest Diagnostics Incorporated
- Laboratory Corporation of America Holdings
- Ulta Lab Tests, LLC
- DHA Laboratory
- Everly Health, Inc.
- ZRT Laboratory LLC
- Danaher Corporation
- Thyrocare Technologies Limited
- Siemens Healthineers AG (Siemens AG)
- Abbott Laboratories
Market Report Segmentation
By End-use- Hospitals
- Diagnostic Laboratories
- Clinics
- Research Laboratories & Institutes
- TSH Test
- Free T4 Test
- T4 Test
- T3 Test
- Free T3 Test
- Others
- US
- Canada
- Mexico
- Rest of North America
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. North America Thyroid Function Testing Market by End-use
Chapter 5. North America Thyroid Function Testing Market by Test Type
Chapter 6. North America Thyroid Function Testing Market by Country
Chapter 7. Company Profiles
Companies Mentioned
- Quest Diagnostics Incorporated
- Laboratory Corporation of America Holdings
- Ulta Lab Tests, LLC
- DHA Laboratory
- Everly Health, Inc.
- ZRT Laboratory LLC
- Danaher Corporation
- Thyrocare Technologies Limited
- Siemens Healthineers AG (Siemens AG)
- Abbott Laboratories
Methodology
LOADING...
